Extracellular ATP in T-lymphocyte activation: possible role in effector functions - PubMed (original) (raw)
Extracellular ATP in T-lymphocyte activation: possible role in effector functions
A Filippini et al. Proc Natl Acad Sci U S A. 1990 Nov.
Erratum in
- Proc Natl Acad Sci U S A 1991 Aug 1;88(15):6899
Abstract
We hypothesized that cytolytic T lymphocytes (CTL) may utilize extracellular ATP (ATPo) during the effector phase of the CTL-target cell interactions and that CTL could be the source of ATPo. It is demonstrated here that incubation of CTL with activating ligands [Con A or monoclonal antibody (mAb) to the T-cell antigen receptor (TCR)] results in the extracellular Ca2(+)-independent accumulation of the ATPo. The addition of the ATP-degrading enzymes into the mixture of CTL and target cells results in a strong inhibition of the CTL-mediated, TCR-triggered lethal-hit delivery to the target cell. In a parallel control experiment, the employed enzymes did not affect target cell-induced, TCR-triggered exocytosis of granules from CTL. Thus, the removal of ATPo with enzymes does not interfere with the activation of CTL by the target cell but does block lytic events. Cloned helper T lymphocytes also accumulate ATPo after incubation with anti-TCR mAb or Con A, suggesting the possibility that ATPo, which acts in concert with ectoprotein kinases and/or purinergic receptors, may be of general use as a messenger in cellular interactions of T lymphocytes.
Similar articles
- The cytolytic T lymphocyte and its mode of action.
Berke G. Berke G. Immunol Lett. 1989 Feb;20(3):169-78. doi: 10.1016/0165-2478(89)90075-8. Immunol Lett. 1989. PMID: 2654015 Review.
Cited by
- The P2X7 receptor in mucosal adaptive immunity.
Grassi F, Marino R. Grassi F, et al. Purinergic Signal. 2024 Feb;20(1):9-19. doi: 10.1007/s11302-023-09939-w. Epub 2023 Apr 17. Purinergic Signal. 2024. PMID: 37067746 Free PMC article. Review. - Epstein-Barr Virus-Positive Lymphomas Exploit Ectonucleotidase Activity To Limit Immune Responses and Prevent Cell Death.
Lange PT, Damania B. Lange PT, et al. mBio. 2023 Apr 25;14(2):e0345922. doi: 10.1128/mbio.03459-22. Epub 2023 Feb 14. mBio. 2023. PMID: 36786572 Free PMC article. - Effector Memory-Expressing CD45RA (TEMRA) CD8+ T Cells from Kidney Transplant Recipients Exhibit Enhanced Purinergic P2X4 Receptor-Dependent Proinflammatory and Migratory Responses.
Doan Ngoc TM, Tilly G, Danger R, Bonizec O, Masset C, Guérif P, Bruneau S, Glemain A, Harb J, Cadoux M, Vivet A, Mai HL, Garcia A, Laplaud D, Liblau R, Giral M, Blandin S, Feyeux M, Dubreuil L, Pecqueur C, Cyr M, Ni W, Brouard S, Degauque N; on behalf on the DIVAT Consortium; DIVAT Consortium. Doan Ngoc TM, et al. J Am Soc Nephrol. 2022 Dec;33(12):2211-2231. doi: 10.1681/ASN.2022030286. Epub 2022 Oct 24. J Am Soc Nephrol. 2022. PMID: 36280286 Free PMC article. - P2 Receptors: Novel Disease Markers and Metabolic Checkpoints in Immune Cells.
Vultaggio-Poma V, Di Virgilio F. Vultaggio-Poma V, et al. Biomolecules. 2022 Jul 14;12(7):983. doi: 10.3390/biom12070983. Biomolecules. 2022. PMID: 35883539 Free PMC article. Review. - Physiologic roles of P2 receptors in leukocytes.
Alberto AVP, Ferreira NCDS, Bonavita AGC, Nihei OK, Farias FP, Bisaggio RDC, Albuquerque C, Savino W, Coutinho-Silva R, Persechini PM, Alves LA. Alberto AVP, et al. J Leukoc Biol. 2022 Nov;112(5):983-1012. doi: 10.1002/JLB.2RU0421-226RR. Epub 2022 Jul 15. J Leukoc Biol. 2022. PMID: 35837975 Free PMC article. Review.
References
- J Immunol. 1985 Jun;134(6):3994-4000 - PubMed
- Proc Natl Acad Sci U S A. 1984 Dec;81(24):7922-6 - PubMed
- FEBS Lett. 1985 Jun 17;185(2):323-7 - PubMed
- J Immunol. 1986 Jan;136(1):23-7 - PubMed
- Biochem J. 1986 Jan 15;233(2):309-19 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous